You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

List of Excipients in API nicotine polacrilex


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing nicotine polacrilex

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 ACACIA
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 ACESULFAME POTASSIUM
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 CARNAUBA WAX
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 HYPROMELLOSE
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 MAGNESIUM OXIDE
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC NICORETTE nicotine polacrilex 0135-0241 MENTHOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing nicotine polacrilex

Company Ingredient NDC Excipient
L Perrigo Company nicotine polacrilex 0113-0029 ACESULFAME POTASSIUM
L Perrigo Company nicotine polacrilex 0113-0029 CALCIUM CARBONATE
L Perrigo Company nicotine polacrilex 0113-0029 CARNAUBA WAX
L Perrigo Company nicotine polacrilex 0113-0029 POLACRILIN
L Perrigo Company nicotine polacrilex 0113-0029 SODIUM BICARBONATE
L Perrigo Company nicotine polacrilex 0113-0029 SODIUM CARBONATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for nicotine polacrilex

Excipient focus: 4-(P-HYDROXYPHENYL)-2-BUTANONE

Excipient focus: ACACIA

Excipient focus: ACESULFAME POTASSIUM

nicotine polacrilex drug variants not containing ACESULFAME POTASSIUM

Company Ingredient NDC
L Perrigo Company nicotine polacrilex 0113-0344
L Perrigo Company nicotine polacrilex 0113-0873
L Perrigo Company nicotine polacrilex 0113-7344
L Perrigo Company nicotine polacrilex 0113-7873
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0510
Haleon US Holdings LLC nicotine polacrilex 0135-0635
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: ACETIC ACID

Excipient focus: ALUMINUM OXIDE

Excipient focus: ALUMINUM SILICATE

Excipient focus: ASPARTAME

Excipient focus: BENZALDEHYDE

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CALCIUM CARBONATE

Excipient focus: CALCIUM POLYCARBOPHIL

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

nicotine polacrilex drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
L Perrigo Company nicotine polacrilex 0113-2502
L Perrigo Company nicotine polacrilex 0113-5023
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0625
Walgreen Company nicotine polacrilex 0363-4049
Walgreen Company nicotine polacrilex 0363-7044
Rite Aid Corporation nicotine polacrilex 11822-1649
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: CORN SYRUP

Excipient focus: D&C YELLOW NO. 10

Excipient focus: ETHYL ACETATE

Excipient focus: ETHYL BUTYRATE

Excipient focus: ETHYL ISOVALERATE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: GELATIN

Excipient focus: GLYCERIN

nicotine polacrilex drug variants containing GLYCERIN

Company Ingredient NDC
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-484
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-486
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-488
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-982
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-984
NuCare PharmaceuticalsInc nicotine polacrilex 68071-2722
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

nicotine polacrilex drug variants containing HYPROMELLOSE

Company Ingredient NDC
L Perrigo Company nicotine polacrilex 0113-2502
L Perrigo Company nicotine polacrilex 0113-5023
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0241
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0474
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0625
Walgreens nicotine polacrilex 0363-3911
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: HYPROMELLOSE 2208

Excipient focus: ICODEXTRIN

Excipient focus: LACTOSE

Excipient focus: LIME OIL

Excipient focus: LIME OIL, COLD PRESSED

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MENTHA ARVENSIS LEAF OIL

nicotine polacrilex drug variants containing MENTHA ARVENSIS LEAF OIL

Company Ingredient NDC
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-484
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-486
Dr Reddy's Laboratories Inc nicotine polacrilex 43598-982
Dr Reddy's Laboratories Inc nicotine polacrilex lozenge 2 mg 43598-986
Chain Drug Marketing Association INC nicotine polacrilex lozenge 2 mg 63868-733
NuCare PharmaceuticalsInc nicotine polacrilex 68071-2722
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: MENTHOL

Excipient focus: MICA

Excipient focus: MODIFIED CORN STARCH

Excipient focus: PEPPERMINT

Excipient focus: PEPPERMINT OIL

nicotine polacrilex drug variants containing PEPPERMINT OIL

Company Ingredient NDC
L Perrigo Company nicotine polacrilex 0113-2502
L Perrigo Company nicotine polacrilex 0113-5023
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0241
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0474
Walgreen Company nicotine polacrilex 0363-4049
Walgreen Company nicotine polacrilex 0363-7044
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: POLACRILIN

Excipient focus: POLYSORBATE 60

Excipient focus: POLYSORBATE 80

nicotine polacrilex drug variants containing POLYSORBATE 80

Company Ingredient NDC
L Perrigo Company nicotine polacrilex 0113-2502
L Perrigo Company nicotine polacrilex 0113-5023
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0241
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0474
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC nicotine polacrilex 0135-0625
Walgreen Company nicotine polacrilex 0363-4049
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: POTASSIUM

Excipient focus: POTASSIUM BICARBONATE

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: RACEMENTHOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ALGINATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CARBONATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SOY PROTEIN

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: XANTHAN GUM

Excipient focus: XYLITOL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group